ScreenerHero

DWTXDogwood Therapeutics Inc. Common Stock

NAS · US · Healthcare · Biotechnology · dwtx.com
2.490USD+7.79%Mkt Cap: 84.64M $P/E: 1.32

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famci…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap84.64M $
Enterprise Value69.72M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-34.26M $
Revenue/Share—
Last Price2.490 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)1.32
P/E (Forward)-0.37
PEG—
EV/EBITDA-2.36
EV/Revenue—
P/S—
P/B0.93
EPS (TTM)1.89
EPS (Forward)-6.37
52W Range
1.28015% of range9.500
52W High9.500 USD
52W Low1.280 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-45.74%
ROA-37.99%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.62M $
CapEx (TTM)—
FCF Margin—
FCF Yield-19.33%
Net Debt-9.48M $
Net Debt/EBITDA0.32
Balance Sheet
Debt/Equity0.00
Current Ratio3.89
Quick Ratio3.39
Book Value/Sh2.518 USD
Cash/Share0.2830 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateOct 9, 2024
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)14.00 USD
Upside (mean)+462.2%
Target Range12.00 USD – 15.00 USD
$12.00+462.2% to mean$15.00
# Analysts3
Ownership
Shares Out.33.99M
Float5.51M
Insiders72.57%
Institutions11.47%
Short Interest
Short Ratio1.0d
Short % Float0.63%
Short % Out.0.22%
Shares Short73.79K
Short (prev mo.)96.25K
Technical
SMA 501.629 (+52.9%)
SMA 2002.887 (-13.7%)
Beta1.76
S&P 52W Chg18.16%
Avg Vol (30d)50.20K
Avg Vol (10d)50.86K
Technical Indicators
RSI (14)81.3
MACD0.1923
MACD Signal0.1227
MACD Hist.+0.0696
BB Upper2.364 USD
BB Middle1.817 USD
BB Lower1.271 USD
BB Width60.10%
ATR (14)0.1713 USD
Vol Ratio (20d)2.38x